Skip to main content
. 2023 Jan 26;18:100164. doi: 10.1016/j.wnsx.2023.100164

Table 6.

Comparison of recent studies on surgically treated cerebellar metastases.

N° patients Median age (range) Synchronous metastases % Single metastases % Complications rate% Peri-operative mortality OS Time to metastasis Adjuvant therapy
Pompili et al.
2008
44 58 (39–83) 23% 93% 20% 9% (1 mo) 8 mo 30 mo 36%
Yoshida et al.
2009
73 57 (42–77) NR 32% NR NR single met
35 mo multiple met
8.4 mo
13.5 mo 48%
Ghods et al.
2011
50 54 (29–81) 34% 64% 4% 0% NR 17 mo NR
Sunderland et al.
2016
92 59 (37–76) 36% 79% 22.8% 7.6% (1 mo) 6 mo NR 73%
Calluaud et al.
2018
120 62 (55–89) 48% 65% 19.1% 1.7% 9 mo 4 mo 82%
Ersoy et al.
2021
73 60 (30–82) 26% 53% 17.8% 6.8% (1 mo) 9 mo NR 73%
Telera et al.
2023
48 69.5 (66–87) 21% 87.5% 29% 23% (3 mo) 7 mo 26 mo 71%